spacer
spacer

PDBsum entry 2o9a

Go to PDB code: 
Top Page protein ligands Protein-protein interface(s) links
DNA binding protein PDB id
2o9a
Contents
Protein chains
182 a.a.
Ligands
EDO ×4
PYR ×4
Waters ×835

References listed in PDB file
Key reference
Title Glyoxylate and pyruvate are antagonistic effectors of the escherichia coli iclr transcriptional regulator.
Authors G.L.Lorca, A.Ezersky, V.V.Lunin, J.R.Walker, S.Altamentova, E.Evdokimova, M.Vedadi, A.Bochkarev, A.Savchenko.
Ref. J Biol Chem, 2007, 282, 16476-16491. [DOI no: 10.1074/jbc.M610838200]
PubMed id 17426033
Abstract
The Escherichia coli Isocitrate Lyase Regulator (IclR) regulates the expression of the glyoxylate bypass operon (aceBAK). Founding member of a large family of common fold transcriptional regulators - IclR comprises a DNA-binding domain that interacts with the operator sequence and a C-terminal domain (C-IclR) that binds a hitherto unknown small molecule. We screened a chemical library of over 150 metabolic scaffolds using a high-throughput protein stability assay to identify molecules that bind IclR, and then tested the active compounds in in vitro assays of operator binding. Glyoxylate and pyruvate, identified by this method bound C-IclR domain with KDs of 0.9 +/- 0.2 mM and 156.2 +/- 7.9 mM, as defined by isothermal titration calorimetry. Both compounds altered IclR interactions with operator DNA in EMSA assays but showed an antagonistic effect. Glyoxylate disrupted the formation of the IclR/operator complex in vitro by favoring the inactive dimeric state of the protein while pyruvate increased the binding of IclR to the aceBAK promoter by stabilizing the active tetrameric form of the protein. Structures of the C-IclR domain alone and in complex with each effector were determined at 2.3 A, confirming the binding of both molecules in the effector recognition site previously characterized for the other representative of the family, the E. coli AllR regulator. Site directed mutagenesis demonstrated the importance of hydrophobic patch formed by Met146, Leu154, Leu220, and Leu143 in interactions with effector molecules. In general, our strategy of combining chemical screens with functional assays and structural studies has uncovered two small molecules with antagonistic effects that regulate the IclR-dependent transcription of the aceBAK operon.
Figure 7.
FIGURE 7. Overall structure of C-IclR. A, schematic diagram of a monomer of the IclR ligand binding domain in complex with glyoxylate (PDB code 2O99). B, C-IclR interdomain interface between two monomers in the (PDB code 2O99) structure. Loops are colored green, helices are red, and -strands are yellow. Glyoxylate is represented as a stick figure in cyan. The N and C termini are labeled.
Figure 12.
FIGURE 12. Functionalanalysisofkeyaminoacidsinvolvedininterdomaininteractionsandeffectorbinding. The glyoxylate and pyruvate binding on mutant IclR proteins was tested by EMSA. The name of the corresponding mutant protein and its concentration used for binding is indicated above each image. Glyoxylate and pyruvate were tested at 1 mM.
The above figures are reprinted by permission from the ASBMB: J Biol Chem (2007, 282, 16476-16491) copyright 2007.
PROCHECK
Go to PROCHECK summary
 Headers

 

spacer

spacer